Surveillance and Genome Analysis of Human Bocavirus in Patients with Respiratory Infection in Guangzhou, China. by Zhou, R et al.
Title Surveillance and Genome Analysis of Human Bocavirus inPatients with Respiratory Infection in Guangzhou, China.
Author(s) Xu, L; He, X; Zhang, DM; Feng, FS; Wang, Z; Guan, LL; Wu, JH;Zhou, R; Zheng, BJ; Yuen, KY; Li, MF; Cao, KY
Citation PLoS One, 2012, v. 7 n. 9, p. e44876
Issued Date 2012
URL http://hdl.handle.net/10722/189291
Rights Creative Commons: Attribution 3.0 Hong Kong License
Surveillance and Genome Analysis of Human Bocavirus
in Patients with Respiratory Infection in Guangzhou,
China
Lin Xu1,2,3., Xia He1,2,3., Ding-mei Zhang1,2,3., Fa-shen Feng1,2,3, Zhu Wang1,2,3, Lin-lin Guan1,2,3, Jue-
heng Wu1,2,3, Rong Zhou4, Bo-jian Zheng3,5, Kwok-yung Yuen3,5, Meng-feng Li1,2,3, Kai-yuan Cao1,2,3*
1Department of Microbiology, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, People’s Republic of China, 2 Key Laboratory of Tropical Disease
Control, Ministry of Education, Sun Yat-Sen University, Guangzhou, People’s Republic of China, 3 Sun Yat-sen University – University of Hong Kong Joint Laboratory of
Infectious Disease Surveillance, Sun Yat-sen University, Guangzhou, People’s Republic of China, 4 State Key Laboratory of Respiratory Diseases, Guangzhou Medical
University, Guangzhou, People’s Republic of China, 5Department of Microbiology, University of Hong Kong, Hong Kong SAR, China
Abstract
Human bocavirus (HBoV) is a novel parvovirus associated with respiratory tract diseases and gastrointestinal illness in adult
and pediatric patients throughout the world. To investigate the epidemiological and genetic variation of HBoV in
Guangzhou, South China, we screened 3460 throat swab samples from 1686 children and 1774 adults with acute respiratory
infection symptoms for HBoV between March 2010 and February 2011, and analyzed the complete genome sequence of 2
HBoV strains. Specimens were screened for HBoV by real-time PCR and other 6 common respiratory viruses by RT-PCR or
PCR. HBoV was detected in 58 (1.68%) out of 3460 samples, mostly from pediatric patients (52/58) and inpatient children
(47/58). Six adult patients were detected as HBoV positive and 5 were emergency cases. Of these HBoV positive cases, 19
(32.76%) had co-pathogens including influenza virus (n = 5), RSV (n = 5), parainfluenza (n = 4), adenovirus (n = 1), coronavirus
(n = 7). The complete genome sequences of 2 HBoVs strains (Genbank no. JN794565 and JN794566) were analyzed.
Phylogenetic analysis showed that the 2 HBoV strains were HBoV1, and were most genetically close to ST2 (GenBank
accession number DQ0000496). Recombination analysis confirmed that HBoV strain GZ9081 was an intra–genotype
recombinant strain among HBoV1 variants.
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Introduction
Human bocavirus (HBoV), recently identified as a new member
of the Parvoviridae family from the respiratory secretions of
children suffering from lower respiratory tract infection [1], has
a single-stranded DNA genome of ,5.2kb, which contains three
open reading frames (ORFs), encoding two non-structural proteins
(NS1 and NP1) and two viral capsid proteins (VPs) [2]. The
nucleotide sequences are highly conserved among HBoVs
circulating in different geographic regions [3], with the VP1/
VP2 gene displaying relatively commonly found nucleotide
polymorphisms [2].
Since its first identification, HBoV has been detected in 1.5%–
19% of respiratory tract secretions [1–15] and 0.8%–9.1% of fecal
samples [13,16–19], respectively, from patients with acute re-
spiratory tract illnesses or gastroenteritis worldwide, It is of note
that most of these reports were mainly derived from young
children and infants, with only a few exceptions testing adult
patients. More recently, three more genotypes of HBoV (HBoV2–
4) were found, [2,20,21], and reports have shown that inter-
genotype and intra-genotype recombinations are present among
bocavirus [22]. All 4 genotypes of HBoV have been identified in
children with acute gastroenteritis (AGE), whereas only HBoV1
and HBoV2 were reported in respiratory tract samples. Due to the
higher rates of co-infections with other pathogens, it remains to be
clarified whether in these diseases HBoVs are the key etiologic
agent or just a concomitant virus bystander.
To better understand the epidemiology of the HBoV infection,
in conjunction of a viral surveillance program, we investigated the
presence of HBoV in patients with acute respiratory infection in
Guangzhou, a city located in south China. Geographically, the city
is characteristics of a tropical-subtropical climate, with the average
annual temperature of 20–22uC and average relative humidity of
77%. The city is also highly populated, with a resident population
of 12.70 million, plus a non-residential population of 4.76 million.
These socio-natural factors make the region generally vulnerable
to air-borne as well as food-borne viral infection. The epidemi-
ological status and genomic characteristics of HBoV prevailing in
pediatric and adult patients with respiratory infection in the
region, however, remains unknown. In our current study, we
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screened throat swab specimens from patients with acute re-
spiratory tract infection symptoms for HBoV and other common
respiratory viruses over a 12-month period using polymerase chain
reaction (PCR) methods, and in addition, the molecular phylogeny
and complete genome sequences of 2 HBoV strains were also
analyzed.
Materials and Methods
Ethics statement
All research involving human participants was approved by the
Medical Ethics Review Board of Zhongshan School of Medicine,
Sun Yat-sen University, in accordance with the guidelines for the
protection of human subjects. Written informed consent was
obtained from each participant/guardian.
Patients and specimens
From March 2010 to February 2011, 3460 throat swabs were
obtained from 1686 children and 1774 adult patients who had
been admitted to five hospitals in Guangzhou, China. They were
only taken from individuals with # 3 days of fever (temperature
$37.5uC), and with cough, sputum, throat sore or other re-
spiratory tract infection symptoms. There were 2009 male and
1451 female patients with age ranging from 1 day to 95 years.
Demographic, epidemiology and clinical information including
case history, symptoms, physical signs and examination results etc.
were collected using a standardized questionnaire. All specimens
were added to 2 ml VTM (consists of Earle’s Balanced Salt
Solution (BioSource International, USA), 4.4% bicarbonate, 5%
bovine serum albumin, 100 mg/mL vancomycin, 30 mg/mL
amikacin, and 40 U/mL nystatin) according to a standard pro-
tocol and transported within 8 hr at 4uC to Biosafety Laboratory
of Sun Yat-Sen university, where they were divided into aliquots,
and stored at 280uC until processing further.
All specimens were tested for 7 common respiratory viruses,
including influenza virus types A, B and C (Inf-A, Inf-B and Inf-C),
parainfluenza (PIV) types 1–4, respiratory syncytial virus (RSV),
human metapneumovirus (HMPV), human coronavirus (HCoV),
adenovirus (AdV) and HBoV using PCR, RT-PCR or real-time
PCR methods as described below. Information of patients whose
throat swabs were found positive for HBoV was analyzed
retrospectively.
Nucleic Acid Extraction
DNA and RNA were simultaneously extracted from 200 ml of
throat swab specimen using QIAamp MiniElute Virus Spin
(QIAGEN, Germany). Reverse transcription of virus RNA was
conducted by Superscript III transcriptase and random hexamer
primers (Invitrogen, Life Technology, USA), both kits were used
according to the manufacturer’s instructions.
Pathogen Screening
Inf-A, -B and -C, PIV -1, -2, -3 and -4, RSV-A and -B, HMPV,
HCoV, and AdV were detected by a standard reverse transcrip-
tion-PCR (RT-PCR) or PCR techniques as previously described
using specific primers listed in Table S1 [11,23–25], and amplified
products were detected by agarose gel electrophoresis.
Screening of HBoV used real-time PCR. The full sequence of
HBoV was referred from the ST2 strain (GenBank accession
number DQ000496, or NC_007455). TaqMan real-time PCR
primers (NP1-F and NP1-R) and probe (synthesized by Invitrogen,
Life Technology, USA) were designed to bind the NP1 highly
conserved region of different HBoV strains and analyzed by
Primer Express software (Version 3.0, Applied Biosystems, USA)
(for primer and probe sequences, see Table 1), with regard to
optimal G–C content (55%, 44% and 60% for NP1-F, NP1-R and
probe, respectively), melting temperature (58.4uC, 59.3uC and
70.0uC for NP1-F, NP1-R and probe, respectively), and amplicon
length (88bp). Each reaction mixture consisted of 10 ml 26 iQ
Supermix reaction mixture (Bio-Rad, USA), 2 mL of viral DNA,
0.5 mM each of the forward and reverse primers, and 0.3 mM of
the probe, and nuclease-free water to a final volume of 20 ml.
Real-time PCR was conducted for 95uC for 15 min, followed by
45 cycles of 95uC for 15 s, 60uC for 1 min on the ABI7500 Real-
time PCR system.
Complete Genome Sequencing for HBoV
The complete genomes of HBoV strains were amplified using
primers designed for complete genome by the Primer Premier 5.0
software to bind relatively conserved regions of HBoV as available
in the GenBank database (primer sequences shown in Table 1).
The PCR was carried out using the Platinum pfx Taq polymerase
(Invitrogen, USA) in a prepared reaction mix according to the
following condition: 95uC for 5 min, followed by 40 cycles of 94uC
for 15 s, 53uC to 58uC (see Table 1 for melting temperature of
different primers) for 45 s, and 68uC for 2 min, and a final
extension at 72uC for 7 min. PCR products for genome analysis
was purified by agarose gel DNA purification kit (Takara, China),
and the PCR products of terminal sequences were cloned into
PCR-blunt 4-Topo vector (Zero Blunt Topo PCR cloning kit for
sequencing, Invitrogen, USA). All PCR products used for cloning
and sequencing were from three independent PCR reactions.
Sequencing was performed by a commercial service of Invitrogen
Co. according to the method described in ref. [26] (Guangzhou,
China) and submitted to the GenBank database.
Phylogenetic Analysis and Recombination Detection
The genomic sequences and ORFs of HBoV were compara-
tively analyzed with complete genome sequences of other HBoV
strains in the GenBank (including HBoV reference strains ST1,
ST2, parvovirus B19, bovine parvovirus, canine minute virus, and
virus strains obtained from several countries). These sequences
were aligned by the Clustal X program, and a neighbor-joining
tree was constructed using the MEGA 4.0 software. Potential
recombinant sequences and parental sequences were analyzed
using the Recombination Detection Program (RDP) [27]. RDP
scanning was performed by GENECONV, BOOTSCAN, Max-
Chi, Chimaera, and SISCAN methods. A Multiple comparison
corrected P-value cutoff of 0.001 was used throughout. Simplot
checking was used to confirm and evaluate localization of possible
recombination break points by BOOTSCAN program [28].
Recombinant validation was done by checking the bilateral gene
sequences of the recombinant site using phylogenetic trees.
Results
Virological Surveillance
Of the 3460 samples collected from patients with respiratory
tract infection symptoms and signs enrolled in the study during the
period between March 2010 and February 2011, detection for 7
viruses, namely, Influenza, PIV, RSV, HMPV, HCoV, AdV and
HBoV, showed that 1275 (36.8%) were found positive for one
single virus and 112 (3.2%) were infected by more than one virus.
As shown in Table 2, 21.1% of patients tested were found positive
for Inf- A, -B, or -C (median age 25 years), 7.7% for RSV (median
age 0.91 years), 4.2% for AdV (median age 5 years), 3.5% for PIV
(median age 1.2 years), 2.7% for HMPV (median age 2 years),
and 2.6% for HCoV (median age 3 years). HBoV DNA was
HBoV Surveillance and Genome Analysis in Guangzhou
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detected in 58 samples (1.68%) (median age 1.5 years) by real-time
PCR, including 52 pediatric (47 inpatient, 4 outpatient and 1
emergency patient) and 6 adult (1 inpatient and 5 emergency
patients) cases.
The monthly distribution of 7 respiratory viruses tested in
patients with indications for respiratory infection from March,
2010 to February, 2011 showed biannual peaks. The highest peak
of total positive rate of HBoV and other 6 common respiratory
viruses appeared in August (56.2%, chi-square test, P,0.05
compared with other months), and another lower peak appeared
in winter to spring (January to March). Interestingly, influenza
virus was prevalent throughout the year, and peaked in August
(Fig. S1). It is also of note that HBoV was detected in nearly all
months except January during the study year, and the peak was
present in May and June (5.4% and 6.3% respectively, Fig. 1).
Patients enrolled in this study aged from 1 day to 95 years,
including 1686 children (#15 years old) and 1774 adults
(.15 years old) with a median age of 16 years. The total infection
rate of common respiratory virus in children is 41.6% (701 positive
out of 1686 pediatric subjects), as compared to that of 38.7% (686
positive out of 1774 adult subjects) in adults, For most of the
screened respiratory viruses, the infection rate of pediatric patients
was higher than adult patients (P,0.05) except influenza virus,
which tended to infect adults (see Fig. S2 for the age distribution of
common respiratory viruses). In contrast to influenza virus, which
displayed a higher infection rate (540 out of 731 influenza-infected
individuals) in adult patients aged from 15 to 64 years old
(Fig. S2), HBoV tended to mostly infect infants younger than
2 years of age (41 out of 58 all HBoV-positive subjects) with a few
adult infection (6 in age .15 years old group amongst 58 all
HBoV-positive subjects). (Fig. 2).
Clinical characteristics of HBoV positive cases
In this study, the common symptoms of patients detected as
HBoV positive included cough (91.4%), fever (100%),rhinorrhea
(36.2%), sputum (36.2%). It is noteworthy that while 43 (74.1%)
out of the 58 HBoV-positive patients were clinically diagnosed as
lower respiratory tract infection including bronchopneumonia,
acute asthmatic bronchopneumonia, and severe pneumonia, only
15 (25.9%) patients met the criteria of severe respiratory infection
as featured by dyspnoea. In addition, 9 (15.5%) of the HBoV-
positive patients were clinically presented as acute upper re-
spiratory tract infection, and 3 were diagnosed, respectively, as
bronchial asthma, herpangina and infectious mononucleosis. Of
note, a 77-year-old patient with acute exacerbation of COPD was
found infected by HBoV without the presence of any of other 6
respiratory viruses tested in this study. This patient displayed
a normal hemogram but a chest radiograph of coarse lung
marking.
To better understand the HBoV pathogenicity, clinical char-
acteristics of HBoV-positive outpatients/emergency cases were
compared with those of HBoV-positive inpatients (Table 3). The
HBoV positive rate in outpatients/emergency was 0.56% (10 out
of 1800 outpatients/emergency cases), significantly lower than that
of 2.89% in inpatients (48 out of 1660 inpatients) (chi-square test,
P,0.01). The odds of infection with HBoV resulting in severe
disease (or admission) were 5.21 (95% CI 2.64–10.25). HBoV
positive pediatric patients were more diagnosed as lower re-
spiratory tract illness than adults in both outpatients and inpatients
(3 out of 5 pediatric vs 0 out of 5 adults in outpatient/emergency
HBoV-positive patients and 40 out of 47 pediatric vs 0 out of 1
adult in inpatients), especially in infants under 2 years old (35 out
of 52 HBoV-positive pediatric patients) (Table 3). In contrast,
HBoV positive adults were mainly diagnosed as acute upper
respiratory tract infection (AURI) (Table 3). HBoV-positive
Table 1. The primers used for HBoV screening and complete sequence analysis.
Primer Sequence (59–39) Position a Melting Temp.(uC) PCR product (bp)
NP1-F AGAGGCTCGGGCTCATATCA 2548–2567 60 88
NP2-R TCTTCATCACTTGGTCTGAGGTCTT 2635–2611
HBoV-probe FAM-AGGAACACCCAATCARCCACCTATCGT-TAMRA 2570–2296
HBoV-1F GCCGGCAGACATATTGGATT 1–20 57 722
HBoV-1R GGACGTGTAGCCAGAAGAGATT 722–701
HBoV-2F GGGAGAAGGACTAAGCAAGAG 615–635 52 784
HBoV-2R GTCAAGCGAAGTAACAGGATG 1398–1378
HBoV-3F GGCACGCCTTATAGAACAAGT 1293–1313 56 800
HBoV-3R GGTAACCACCGCAATCAGT 2092–2074
HBoV-4F GAGATTGCAGCTCTTCTACAG 1912–1932 58 729
HBoV-4R CCTCGTCTTCATCACTTGGT 2640–2621
HBoV-5F AAGACAAGCATCGCTCCTAC 2429–2448 55 719
HBoV-5R ACAGGTTCACCGTTATCAAGT 3147–3127
HBoV-6F CACAGACAGAAGCAGACGAGAT 2990–3011 55 776
HBoV-6R GGTGAGAAGTGACAGCTGTATTG 3765–3743
HBoV-7F TGGTCACCTCTACAAAACAGA 3646–3666 55 742
HBoV-7R GTCTGATGACTGTGGTCCTACT 4387–4366
HBoV-8F TCCCAACAAGAAGAGTTCAGT 4242–4262 56.2 1058
HBoV-8R TGTACAACAACAACACATTAAAAG 5299–5276
aAccording to GenBank assession number NC_007455.
doi:10.1371/journal.pone.0044876.t001
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pediatric inpatients were more likely to be co-infected with other
viruses than adult inpatients. However, HBoV-positive adult
outpatients were more frequently co-infected with influenza than
pediatric outpatients, and the reason may lie in the high influenza
infection rate in adults (Table 2 and Table 3).
Co-infection
The surveillance data of 7 common respiratory viruses showed
that among the 3460 samples, 112 were tested as more than one
virus positive. Although influenza was the most common co-
infecting virus, the highest co-infection rate occurred in HCoV
and HBoV (Table 4). In 19 of 58 HBoV positive specimens
(32.76%), other virus can be found, and HCoV was the most
commonly co-detected virus with HBoV, accounting for 7 out of
19 (36.84%) HBoV co-infection cases. There were totally 8 triple
virus co-infection cases (Table 4). It is noteworthy that despite of
the high co-infection rate, in as high as 67.24% HBoV-positive
patients, no other screened common respiratory virus was found,
especially in pediatric patients (36/52, 69.2%), and most of them
Table 2. Screening results of respiratory viruses in 3460 patients.
Hospital group Case number Positive numbers (infection rate %)
Inf PIV RSV HMPV HCoV ADV HBoV
Outpatient 782 215(27.49) 12(1.53) 26(3.32) 19(2.43) 15(1.92) 29(3.71) 4(0.51)
Infants 101 11(10.89) 5(4.95) 18(17.82) 1(0.99) 2(1.98) 7(6.93) 4(3.96)
Children 76 14(18.42) 3(3.95) 5(6.58) 2(2.63) 1(1.32) 10(13.16) 0
Adults 605 190(31.40) 4(0.66) 3(0.5) 16(2.64) 12(1.98) 12(1.98) 0
Emergency case 1018 366(35.95) 25(2.46) 5(0.49) 8(0.79) 15(1.47) 30(2.95) 6(0.59)
Infants 39 2(5.13) 5(12.82) 4(10.26) 0 1(2.56) 1(2.56) 1(2.56)
Children 83 1(1.2) 7(8.43) 0 0 2(2.41) 9(10.84) 0
Adults 896 363(40.51) 13(1.45) 1(0.11) 8(0.89) 12(1.34) 20(2.23) 5(0.56)
Inpatient 1660 150(9.04) 83(5.00) 236(14.22) 67(4.04) 60(3.61) 88(5.30) 48(2.89)
Infants 913 91(9.97) 63(6.9) 203(22.23) 48(5.26) 38(4.16) 33(3.61) 36(3.94)
Children 474 45(9.49) 19(4.01) 24(5.06) 18(3.8) 13(2.74) 36(7.59) 11(2.32)
Adults 273 14 (5.13) 1(0.37) 9(3.3) 1(0.37) 9(3.3) 19(6.96) 1(0.37)
Total 3460 731 (21.13) 120 (3.47) 267 (7.72) 94 (2.72) 90 (2.60) 147 (4.25) 58 (1.68)
Infants/Children 1686 164 (9.73) 102 (6.05) 254 (15.07) 69 (4.09) 57 (3.38) 96 (5.69) 52 (3.08)
Adults 1774 567 (31.96) 18 (1.01) 13 (0.73) 25 (1.41) 33 (1.86) 51 (2.87) 6 (0.34)
Throat swabs of 3460 patients with acute respiratory infection symptoms during 2010–2011 were collected and screened for influenza (Inf), parainfluenza (PIV),
respiratory syncytial virus (RSV), human metapneumovirus (HMPV), human coronaviruses (HCoV), adenovirus (AdV) and human bocavirus (HBoV). Positive case numbers
for each screened virus and their corresponding infection rate (% of positive cases in detected patients) were shown, Infants: #2 years old, children: 2,15 years old,
adults: .15 years old. Among 731 Inf patients, 558 and 172 were positive for influenza A and B, respectively, but only 1 was positive for C (Fig. S1A). In 558 cases
positive for influenza A, 85.13% and 0.72% were identified to be seasonal influenza H3N2 and H1N1, respectively, while 14.15% were found to be 2009 pandemic
influenza H1N1. Among 120 cases positive for PIV, 25%, 12.5%, 58.33% and 4.17% were identified to be PIV-1, -2, -3 and -4, respectively (Fig. S1B). Among 90 patients
positive for HCoV, 62 cases were identified to be infected by 229E, OC43, NL63 and HKU1, in which infection rates of children vs adults were 0.65% vs 0.17%, 1.13% vs
0.17%, 0.65% vs 0.17% and 0.71% vs 0.06%, respectively.
doi:10.1371/journal.pone.0044876.t002
Figure 1. Monthly distribution of HBoV from 3460 patients
with acute respiratory infection symptoms during 2010–2011.
Human bocavirus (HBoV)-positive case number of each month from
March 2010 to February 2011 and the monthly detection rate (% of
monthly detected cases) were shown.
doi:10.1371/journal.pone.0044876.g001
Figure 2. Age distribution of HBoV-positive patients from 3460
patients with acute respiratory infection symptoms during
2010–2011. The number of HBoV-positive patients in different age
groups and the corresponding detection rate (% of detected cases in
corresponding age group) were shown.
doi:10.1371/journal.pone.0044876.g002
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(23/36, 63.89%) were diagnosed as bronchopneumonia. No
correlation was found between co-infection and clinical symptoms,
and among the 19 HBoV co-infection cases, 14 was diagnosed as
lower respiratory tract illness, not statistically higher than that of
HBoV single positive patients (14/19 vs 29/39, P.0.05).
Sequences and phylogenetic analysis
The complete genomes of two HBoV strains GZ4785 (Genbank
no. JN794565) and GZ9081 (Genbank no. JN794566) obtained in
this study were highly conserved with 98.8% identity to each
other, and showed more than 99% nucleotide identity to ST2
strain of HBoV1 (GenBank accession no. DQ0000496). HBoV
strains used in the phylogenetic analysis included the strains
obtained in this study in Guangzhou (GZ4785 and GZ9081),
representative strains of HBoV1-4, human parvovirus B19,
bovine, and canine minute virus. Based on complete genome,
the phylogenetic analysis results showed that the two Guangzhou
strains GZ4785 and GZ9081 were genetically close to HBoV1
(Fig. 3), consistent with the sequence comparison analysis results.
From the phylogenetic tree based on complete genome, different
strains of HBoV1 were clearly divided into three groups (Fig. 4A),
and the representative strain of group I and group II was the
prototype strains ST1 and ST2, respectively. Group III included 4
strains which came from Taiwan, Thailand, and Guangzhou.
Most Chinese strains obtained from respiratory specimens
belonged to group I, but it is noteworthy that GZ9081 strain
obtained in this study belonged to group III. No apparently
genotypic differences existed between the phylogenetic trees based
on the 3 HBoV ORFs (NS1, NP1 and VP1/VP2) and the
complete genome of 23 HBoV1 strains (Fig. 4B–D). Similar to
previous studies [2,24], NS1 appeared to be the most conserved
gene, whereas VP1/VP2 had the most nucleotide polymorphisms.
The phylogenetic trees were almost identical between VP1/VP2
gene and complete genome, which indicated that VP1/VP2 can
be used instead of complete genome to analyze the genetical
relationship of HBoVs.
Recombination Detection
In phylogenetic analysis, we found that HBoV strain GZ9081
belonged to a group different from most of Chinese strains
obtained from respiratory specimens. Interestingly, full-length
genome analysis showed that GZ9081 strain contained an NS1
Table 3. Clinical characteristics in HBoV-positive outpatient/emergency and inpatient groups.
Characteristics Outpatient/emergency Inpatient
Infant/children (%) Adult(%) Infant(%) Children(%) Adult(%)
Patients, total no. 299 1501 913 474 273
HBoV-positive no. 5 5 36 11 1
HBoV-positive Male/Female 2/3 3/2 26/10 6/5 1/0
HBoV-positive Mean temperature(uC) 38.28 38.86 38.11 37.84 37.5
HBoV-positive patient Diagnosis
AURI 1(20) 5(100) 2(5.56) 1(9.09) 0
Acute asthmatic bronchopneumonia 0 0 7(19.44) 2(18.18) 0
Bronchopneumonia 3(60) 0 24(66.67) 6(50.45) 0
Severe pneumonia 0 0 1(2.78) 0 0
Bronchial asthma 0 0 1(2.78) 0 0
COPD 0 0 0 0 1(100)
Herpangina 0 0 0 1(9.09) 0
Infectious mononucleosis 0 0 0 1(9.09) 0
HBoV-positive patient Clinical signs
Cough 5(100) 5(100) 35(97.22) 7(63.64) 1(100)
Rhinorrhea 2(40) 4(80) 12(33.33) 3(27.27) 0
Sputum production 1(20) 1(20) 15(41.67) 3(27.27) 1(100)
Dyspnea 1(20) 0 12(33.33) 1(9.09) 1(100)
Diarrhea 0 0 1(2.78) 0 0
HBoV Copathogens
Influenza virus 0 3(60) 0 2(18.18) 0
Parainfluenza virus 0 0 4(11.11) 0 0
RSV 0 0 5(13.89) 0 0
Human coronavirus 1(20) 1(20) 3(8.33) 2(18.18) 0
Adenovirus 0 0 1(2.78) 0 0
HBoV Coinfection 1(20) 3(60) 11(30.56) 4(36.36) 0
Of the 3460 cases with acute respiratory infection symptoms, totally 58 cases were detected as HBoV-positive. Because no outpatient/emergency 2,15 years old
children was detected positive for HBoV, there were only 2 columns listed as infant/children and adult in outpatient/emergency patients. HBoV, human bocavirus; RSV,
respiratory syncytial virus; AURI, acute upper respiratory tract infection; COPD, chronic obstructive pulmonary disease. Infant: #2 years old, children: 2,15 years old,
adults: .15 years old.
doi:10.1371/journal.pone.0044876.t003
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gene closely homologous to that of the ST1 group, and that the
rest of its genome (NP1 and VP1/VP2 genes) resembled the CU74
group, suggesting that GZ9081 might represent a hybrid virus,
prompting us to conduct the recombinant analysis on this strain.
Therefore, RDP was further carried out. The BootScan plot of the
recombination event was showed in Fig. 5, which confirmed the
daughter linage GZ9081 was a recombinant of parental strains
ST1 and CU74. Two trees of the relevant strain were constructed
respectively on the recombinant region (position: 1–1272+4385-
end) and non- recombinant region (position: 1272–4385), which
further confirmed that GZ9081 was closely related with ST1 on
the recombinant region (Fig. 5). It was very probable that GZ9081
was an HBoV1 intra-genotypic recombinant.
Discussion
Human bocavirus (HBoV) was a newly discovered Parvoviridae
virus. By now, little is known about its epidemiology and genetic
characteristics in Guangzhou, China. The pathogenicity of HBoV
is still in uncertain because of its high co-infection rate with other
pathogens, and it remains unclear whether HBoVs are sole
etiologic agent or just a concomitant virus bystander. Therefore, to
understand the prevailing status and pathogenicity of HBoV, other
pathogens needed to be simultaneously examined. So in this study,
a surveillance of 12 months period during 2010–2011 in
Guangzhou was established to understand the prevalence and
pathogenicity of HBoV in patients with acute respiratory infection
symptoms. Other 6 common respiratory viruses (influenza virus,
parainfluenza virus, adenovirus, coronavirus, RSV, metapneumo-
virus) were screened at the same time to understand their co-
infection status with HBoV. The results revealed that the overall
monthly distribution of HBoV and other 6 common respiratory
viruses were typical, in accordance with the epidemics of
respiratory viruses in tropical/subtropical areas like Guangzhou,
which demonstrated that the surveillance data in this study were
highly reliable. It is notable that HBoV, like RSV, tended to
mainly infect #2 year old infants, with only a few adult infections,
and the majority of the HBoV positive patients (67.24% of all
HBoV positive patients and 69.23% of HBoV positive children)
were HBoV single positive, indicating it may have potential
pathogenicity, especially in infants. Therefore, to better elucidate
its pathogenic roles, the clinical characteristics of HBoV-positive
outpatients/emergency cases were analyzed for comparison with
HBoV-positive inpatients (Table 3). The results showed that the
HBoV positive rate in outpatients/emergency was statistically
lower than inpatients, and the odds of infection with HBoV
resulting in severe disease (or admission) were as high as 5.21.
HBoV positive pediatric patients were more diagnosed as lower
respiratory tract illness than adults in both inpatients and
outpatients, and pediatric inpatients were more likely coinfected
with other viruses. Although there was possibility that other co-
pathogens not be screened in this study may exist, these results
showed that HBoV may have pathogenic role in causing severe
disease/admission or lower respiratory tract illness of children. In
addition, our results showed that HBoV was related to asthma or
its exacerbation, which occurred in 10 pediatric patients.
Previously, only limited data in adults were available for the
study of HBoV, especially in large samples. Many reports of adult
HBoV infection enrolled no more than 100 samples
[2,8,12,29,30]. The prevalence and associated illness of HBoV
Table 4. The co-infection cases of 7 common respiratory
viruses including Inf, PIV, RSV, HMPV, HCoV, AdV and HBoV.
Co-detected viruses Patient No. (%)
Inf, RSV 23 (20.54)
Inf, PIV 9 (8.04)
Inf, HCoV 12 (10.71)
Inf, HMPV 7 (6.25)
Inf, HBoV 4 (3.57)
Inf, AdV 6 (5.36)
PIV, RSV 7 (6.25)
PIV, HCoV 4 (3.57)
PIV, HMPV 3 (2.68)
PIV, HBoV 3 (2.68)
PIV, AdV 2 (1.79)
RSV, HCoV 2 (1.79)
RSV, HMPV 1 (0.89)
RSV, HBoV 3 (2.68)
RSV, AdV 6 (5.36)
HCoV, HMPV 2 (1.79)
HCoV, AdV 4 (3.57)
HCoV, HBoV 5 (4.46)
HBoV, AdV 1 (0.89)
Inf, RSV, HCoV 1 (0.89)
Inf, PIV, AdV 1 (0.89)
Inf, HCoV, HBoV 1 (0.89)
RSV, HCoV, HBoV 1 (0.89)
RSV, HCoV, AdV 1 (0.89)
PIV, RSV, HCoV 1 (0.89)
PIV, RSV, HBoV 1 (0.89)
HCoV, HMPV, AdV 1 (0.89)
Influenza (Inf), parainfluenza (PIV), respiratory syncytial virus (RSV), human
metapneumovirus (HMPV), human coronavirus (HCoV), adenovirus (AdV) and
human bocavirus (HBoV) were screened during 2010–2011 in Guangzhou,
China. Totally 112 cases were detected as more than one virus positive from
3460 patients with acute respiratory infection symptoms. Among them 8 cases
were triple virus positive, and 19 cases were co-infection of HBoV and other
viruses.
doi:10.1371/journal.pone.0044876.t004
Figure 3. Phylogenetic analysis of human bocavirus based on
complete genome. Phylogenetic tree with 1,000 bootstrap replicates
was generated using the neighbor-joining method with Mega 4
software. Parvovirus B19, bovine parvovirus, canine minute virus, and
representative strains of HBoV1-4 were used as reference strains for
genotype analysis of GZ4785 (labeled with red triangle) and GZ9081
(labeled with blue diamond). The HBoV strains obtained in this study
GZ4785 and GZ9081 were identified as HBoV1.
doi:10.1371/journal.pone.0044876.g003
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Figure 4. Phylogenetic analysis of GZ4785, GZ9081, and other reference strains based on full length (A), complete NS1 (B), NP1 (C),
and VP1/VP2 (D) gene sequences. Phylogenetic trees (1,000 bootstrap replicates, Kimura two-parameter model) based on GZ4785 (labeled with
red triangle), GZ9081 (labeled with blue diamond), and other HBoV1 reference strains. Swedish prototype strains ST1 and ST2, American strain CRD2,
Japanese strain JPOC07–511, Thai strains CU6 and CU74, Taiwanese strains TW925_07, TW2715_06 and TW2717_06, Chinese strains HK1, HK19, WLL–
1, WLL–2, CZ643, FZ1, FZ40, BJ3064, BJ3722, GD-HBoV-571, GD-HBoV-594, GD-HBoV-621 were used (GenBank accession no. DQ000495, DQ000496,
DQ340570, AB481080, EF203920, EF203922, EU984245, EU984232, EU984233, EF450717, EF450735, DQ778300, EF441262, DQ457413, GQ455988,
GQ455987, DQ988933, DQ988934, GQ926981, GQ926982, GQ926982).
doi:10.1371/journal.pone.0044876.g004
Figure 5. Identification of recombination event between CU74 and ST1, which led to the recombinant strains GZ9081. BOOTSCAN
evidence for the recombination origin on the basis of pair-wise distance, modeled with a window size 1000, step size 10, and 100 Bootstrap
replicates; The right part of the panel were phylogenetic trees constructed based on recombination regions (1–1272+4385-end) and non-
recombination regions (1272–4385) using Mega 4 software.
doi:10.1371/journal.pone.0044876.g005
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in adults have not been well characterized in Guangzhou. In our
study, we found 6 HBoV-positive adult cases in 1774 adult patients
with upper respiratory tract infection, and the 3.4% prevalence
rate was in accordance with those previously reported for adults
[2,8,12,29,30]. Although HBoV infection was rare in adults with
respiratory infection in our study population, it was still notable
that HBoV may cause exacerbation in adults with basic or primary
pulmonary disease like COPD. We found 52 HBoV-positive
pediatric patients, which represented 3.1% positive rate in
pediatric patients with respiratory infection. This is similar to
other reports of 1.5%–19%. Consistent with other studies [2,8,30],
the prevalence rates were higher in children under 2 years of age,
but generally decrease with the increase of age (Fig. 2), which
implied that antibodies against HBoV acquired during early life
may provide protection.
In our study, up to 32.76% co-infection rate of HBoV was
observed from throat samples, and the rate may be higher if more
viruses were screened. The most frequently detected co-pathogen
was HCoV, different from previous reports in China [12,15], and
the reason may lie in different climate/geography conditions and
virus distribution. There was no obvious evidence that co-infection
of HBoV and other common respiratory viruses can increase the
disease severity, since no correlation was found between co-
infection and clinical symptoms, and the rate of lower respiratory
tract illness did not increase in co-infection cases.
In order to improve the diagnostic sensitivity, our present study
employed real-time PCR to screen HBoV with the primers and
probes binding the NP1 conserved region. To exclude PCR
contamination and prevent false positive and false negative results
in HBoV and other 6 common respiratory viruses screening, the
following strategies were used. Firstly, all PCR was strictly carried
out in 4 separate rooms, namely, reagent preparation, sample
preparation, PCR and PCR-product rooms. Secondly, each PCR/
real-time PCR assay was performed in duplicates and repeated
three times. Thirdly, positive samples were further confirmed by
PCR using another set of primers, and for some of the 6 common
respiratory viruses positive samples, viral isolation and determi-
nation was performed to further confirm the PCR positive results.
Complete genome sequence of 2 HBoV strains were obtained in
our study. Gene analysis showed high identity (98.8%) between
each other, and phylogenetic analysis demonstrated that they
belonged to HBoV1, which was more frequently detected in
respiratory tract illness than other genotypes. Phylogenetic tree of
complete genome showed that different strains of HBoV1 can be
divided into three groups. It is noteworthy that the two strains
identified in this study (GZ4785 and GZ9081), which were
circulating at the same time during the 1 year study period,
belonged to different groups. Furthermore, our phylogenetic
analysis results showed that most Chinese HBoV1 strains obtained
from respiratory samples belonged to group I which was
genetically closely to ST2, but GZ9081 was different, which
belonged to group III. Phylogenetic trees based on different HBoV
ORFs showed that its NS1 gene was closely homologous to the
ST1 group, whereas its NP1 and VP1/VP2 genes resembled the
CU74 group, suggesting it may be a recombinant. Although
generally HBoV1 sequences were highly conserved, there were still
evidences that the recombination existed among HBoVs [22], and
co-infection of HBoVs [20] might increase the chance of
recombination between HBoVs. Therefore, we suspect that
GZ9081 may be a hybrid virus. So a recombinant detection
program was performed to analyze GZ9081. The result confirmed
that GZ9081 was an intra-genotype of HBoV1 recombinant,
originated from the parental strains ST1 and CU74 (Fig. 5). As far
as we know, this is the first time that recombination between
HBoV1 is reported and this is the first recombinant strain of
HBoV1 reported in China. Since recombination could change
virulence or antigenicity of viruses, we believe that the finding of
HBoV recombination might have significance on the epidemiol-
ogy, seroprotection and pathogenicity study of HBoV. Further
studies are needed to examine the virulence and antigenic changes
of GZ9081 strain. Continuous surveillance and genome sequence
analysis are needed to obtain more information on the genotypic
variation and molecular evolution of HBoV in China.
Supporting Information
Figure S1 Monthly distribution of 6 common respira-
tory viruses from 3460 patients with acute respiratory
infection symptoms from March 2010 to February 2011.
Virus-positive case number of each month and the monthly
detection rate (% of monthly detected cases) were shown. (A)
inuenza virus (Inf); (B) parainuenza virus (PIV); (C) respiratory
syncytial virus (RSV); (D) adenovirus (AdV); (E) human metap-
neumovirus (HMPV); (F) human coronavirus (HCoV).
(TIF)
Figure S2 Age distribution of 6 common respiratory
viruses from 3460 patients with acute respiratory
infection symptoms from March 2010 to February
2011. The number of virus-positive patients of different age
groups, and the corresponding detection rate (% of detected cases
in corresponding age group) were shown. (A) inuenza virus (Inf);
(B) parainuenza virus (PIV); (C) respiratory syncytial virus (RSV);
(D) adenovirus (AdV); (E) human metapneumovirus (HMPV); (F)
human coronavirus (HCoV).
(TIF)
Table S1 The primers used for Inf, PIV, RSV, HMPV,
HCoV and AdV screening. Inf: Influenza, PIV: parainfluenza,
RSV: respiratory syncytial virus, HMPV: human metapneumo-
virus, HCoV: human coronavirus, AdV: adenovirus.
(DOC)
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